Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Baquer

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cancer Cell|January 13, 2026
Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Analytical Chemistry|November 7, 2025
Spatial Profiling of Elements through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry ImagingSylwia A Stopka, Clément Bodineau, Gerard Baquer, et al.
Cell Reports|October 12, 2022
PARP-inhibition reprograms macrophages toward an anti-tumor phenotypeLin Wang, Dan Wang, Olmo Sonzogni, et al.
Nature Communications|August 16, 2022
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Shu Wang, Sylwia A Stopka, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent GlioblastomaEudocia Q Lee, Brian M Alexander, Carlos G Romo, et al.
Cell|February 7, 2025
GUK1 activation is a metabolic liability in lung cancerJaime L Schneider, Kiran Kurmi, Yutong Dai, et al.
Science (New York, N.Y.)|September 29, 2022
Oncometabolite d-2HG alters T cell metabolism to impair CD8<sup>+</sup> T cell functionGiulia Notarangelo, Jessica B Spinelli, Elizabeth M Perez, et al.
Molecular Cancer Therapeutics|October 23, 2024
DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway DeficitsSonja Dragojevic, Emily J Smith, Michael S Regan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cancer Cell|January 13, 2026
Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Analytical Chemistry|November 7, 2025
Spatial Profiling of Elements through Matrix-Assisted Laser Desorption Ionization Mass Spectrometry ImagingSylwia A Stopka, Clément Bodineau, Gerard Baquer, et al.
Cell Reports|October 12, 2022
PARP-inhibition reprograms macrophages toward an anti-tumor phenotypeLin Wang, Dan Wang, Olmo Sonzogni, et al.
Nature Communications|August 16, 2022
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastomaShannon Coy, Shu Wang, Sylwia A Stopka, et al.
Neuro-Oncology Advances|June 16, 2023
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse modelsJason E Conage-Pough, Sylwia A Stopka, Ju-Hee Oh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent GlioblastomaEudocia Q Lee, Brian M Alexander, Carlos G Romo, et al.
Cell|February 7, 2025
GUK1 activation is a metabolic liability in lung cancerJaime L Schneider, Kiran Kurmi, Yutong Dai, et al.
Science (New York, N.Y.)|September 29, 2022
Oncometabolite d-2HG alters T cell metabolism to impair CD8<sup>+</sup> T cell functionGiulia Notarangelo, Jessica B Spinelli, Elizabeth M Perez, et al.
Molecular Cancer Therapeutics|October 23, 2024
DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway DeficitsSonja Dragojevic, Emily J Smith, Michael S Regan, et al.
Pageof 3